REVVITY, INC Foreign Currency Transaction Gain (Loss), before Tax
REVVITY, INC (RVTY) reported Foreign Currency Transaction Gain (Loss), before Tax of $1.10 million for the 3-month period ending 2021-10-03, per its 10-Q filed 2021-11-09.
Discontinued › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2021-11-09
- REVVITY, INC foreign currency transaction gain (loss), before tax for the quarter ending 2021-10-03 was $1.10M, a 42.11% decline year-over-year.
- REVVITY, INC foreign currency transaction gain (loss), before tax for the quarter ending 2021-07-04 was $800.00K, a 87.50% decline year-over-year.
- REVVITY, INC foreign currency transaction gain (loss), before tax for the quarter ending 2021-04-04 was -$1.30M.
- REVVITY, INC foreign currency transaction gain (loss), before tax for the quarter ending 2021-01-03 was $4.30M, a 59.26% increase year-over-year.
- REVVITY, INC foreign currency transaction gain (loss), before tax for fiscal 2021 was $2.70M.
- REVVITY, INC foreign currency transaction gain (loss), before tax for fiscal 2019 was -$6.50M, a 169.15% decline from fiscal 2018.
- REVVITY, INC foreign currency transaction gain (loss), before tax for fiscal 2018 was $9.40M, a 67.81% decline from fiscal 2017.
- REVVITY, INC foreign currency transaction gain (loss), before tax for fiscal 2017 was $29.20M, a 1846.67% increase from fiscal 2017.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2021-10-03 | $1.10M 10-Q · filed 2021-11-09 | $1.90M derived: sum of 2 quarters · filed 2021-11-09 | $500.00K 10-Q · filed 2021-11-09 | $4.90M derived: sum of 4 quarters · filed 2021-11-09 | |
| 2021-07-04 | $800.00K 10-Q · filed 2021-08-10 | -$600.00K 10-Q · filed 2021-08-10 | $3.80M derived: sum of 3 quarters · filed 2021-08-10 | $5.70M derived: sum of 4 quarters · filed 2021-11-09 | |
| 2021-04-04 | -$1.30M 10-Q · filed 2021-05-11 | $3.00M derived: sum of 2 quarters · filed 2021-05-11 | $4.90M derived: sum of 3 quarters · filed 2021-11-09 | $11.30M derived: sum of 4 quarters · filed 2021-11-09 | |
| 2021-01-03 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $6.20M derived: sum of 2 quarters · filed 2021-11-09 | $12.60M derived: sum of 3 quarters · filed 2021-11-09 | $2.70M 10-K · filed 2021-03-02 | |
| 2020-10-04 | $1.90M 10-Q · filed 2021-11-09 | $8.30M derived: sum of 2 quarters · filed 2021-11-09 | -$1.60M 10-Q · filed 2021-11-09 | $3.10M derived: sum of 4 quarters · filed 2021-11-09 | |
| 2020-07-05 | $6.40M 10-Q · filed 2021-08-10 | -$3.50M 10-Q · filed 2021-08-10 | $1.20M derived: sum of 3 quarters · filed 2021-08-10 | -$3.50M derived: sum of 4 quarters · filed 2021-08-10 | |
| 2020-04-05 | -$7.90M 10-Q · filed 2021-05-11 | -$5.20M derived: sum of 2 quarters · filed 2021-05-11 | -$9.90M derived: sum of 3 quarters · filed 2021-05-11 | -$14.30M derived: sum of 4 quarters · filed 2021-05-11 | |
| 2019-12-29 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | -$2.00M derived: sum of 2 quarters · filed 2021-03-02 | -$6.40M derived: sum of 3 quarters · filed 2021-03-02 | -$6.50M 10-K · filed 2021-03-02 | |
| 2019-09-29 | -$4.70M 10-Q · filed 2020-11-10 | -$9.10M derived: sum of 2 quarters · filed 2020-11-10 | -$9.20M 10-Q · filed 2020-11-10 | -$8.60M derived: sum of 4 quarters · filed 2021-03-02 | |
| 2019-06-30 | -$4.40M 10-Q · filed 2020-08-11 | -$4.50M 10-Q · filed 2020-08-11 | -$3.90M derived: sum of 3 quarters · filed 2021-03-02 | -$8.20M derived: sum of 4 quarters · filed 2021-03-02 | |
| 2019-03-31 | -$100.00K 10-Q · filed 2020-05-12 | $500.00K derived: sum of 2 quarters · filed 2021-03-02 | -$3.80M derived: sum of 3 quarters · filed 2021-03-02 | -$16.70M derived: sum of 4 quarters · filed 2021-03-02 | |
| 2018-12-30 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | -$3.70M derived: sum of 2 quarters · filed 2021-03-02 | -$16.60M derived: sum of 3 quarters · filed 2021-03-02 | $9.40M 10-K · filed 2021-03-02 | |
| 2018-09-30 | -$4.30M 10-Q · filed 2019-11-05 | -$17.20M derived: sum of 2 quarters · filed 2019-11-05 | $8.80M 10-Q · filed 2019-11-05 | $32.60M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-07-01 | -$12.90M 10-Q · filed 2019-08-06 | $13.10M 10-Q · filed 2019-08-06 | $36.90M derived: sum of 3 quarters · filed 2020-02-25 | $39.60M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-04-01 | $26.00M 10-Q · filed 2019-05-07 | $49.80M derived: sum of 2 quarters · filed 2020-02-25 | $52.50M derived: sum of 3 quarters · filed 2020-02-25 | $53.70M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2017-12-31 | $23.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $26.50M derived: sum of 2 quarters · filed 2020-02-25 | $27.70M derived: sum of 3 quarters · filed 2020-02-25 | $29.20M 10-K · filed 2020-02-25 | |
| 2017-10-01 | $2.70M 10-Q · filed 2018-11-06 | $3.90M derived: sum of 2 quarters · filed 2018-11-06 | $5.40M 10-Q · filed 2018-11-06 | $8.80M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-07-02 | $1.20M 10-Q · filed 2018-08-07 | $2.70M 10-Q · filed 2018-08-07 | $6.10M derived: sum of 3 quarters · filed 2019-02-26 | $7.70M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-04-02 | $1.40M 10-Q · filed 2018-05-08 | $4.90M derived: sum of 2 quarters · filed 2019-02-26 | $6.50M derived: sum of 3 quarters · filed 2019-02-26 | $7.10M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-01-01 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $5.10M derived: sum of 2 quarters · filed 2019-02-26 | $5.70M derived: sum of 3 quarters · filed 2019-02-26 | $1.50M 10-K · filed 2019-02-26 | |
| 2016-10-02 | $1.60M 10-Q · filed 2017-11-07 | $2.20M derived: sum of 2 quarters · filed 2017-11-07 | -$2.00M 10-Q · filed 2017-11-07 | -$3.40M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-07-03 | $600.00K 10-Q · filed 2017-08-08 | -$3.50M 10-Q · filed 2017-08-08 | -$5.00M derived: sum of 3 quarters · filed 2018-02-27 | -$3.70M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-04-03 | -$4.20M 10-Q · filed 2017-05-09 | -$5.60M derived: sum of 2 quarters · filed 2018-02-27 | -$4.30M derived: sum of 3 quarters · filed 2018-02-27 | -$13.70M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-01-03 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$100.00K derived: sum of 2 quarters · filed 2018-02-27 | -$9.50M derived: sum of 3 quarters · filed 2018-02-27 | -$25.30M 10-K · filed 2018-02-27 | -$25.50M 10-K · filed 2016-03-01 |
| 2015-10-04 | $1.30M 10-Q · filed 2016-11-08 | -$8.10M derived: sum of 2 quarters · filed 2016-11-08 | -$23.90M 10-Q · filed 2016-11-08 | ||
| 2015-06-28 | -$9.40M 10-Q · filed 2016-08-09 | -$25.20M 10-Q · filed 2016-08-09 | |||
| 2015-03-29 | -$15.80M 10-Q · filed 2016-05-10 | ||||
| 2014-12-28 | -$5.50M 10-K · filed 2017-02-28 | ||||
| 2013-12-29 | -$4.70M 10-K · filed 2016-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |